Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 84 | 1 | 72 | −11 |
| Shares | 22.8M | 10.2K | 23.3M | +524.6K (+2.3%) |
| Value | $44.4M | $22.0K | $59.8M | +$15.4M (+34.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplex Trading, LLC | 258,285 | $663.0K | 0.03% |
| Jane Street Group, LLC | 14,020 | $36.0K | 0.00% |
| Walleye Capital LLC | 12,000 | $31.0K | 0.00% |
| Key Financial Inc | 475 | $1.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 514 | $1.00K | 0.00% |
Sold out (16)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fortress Investment Group LLC | 809,651 | $1.56M |
| Pictet Asset Management SA | 481,827 | $930.0K |
| Gsa Capital Partners LLP | 33,571 | $65.0K |
| Principal Financial Group Inc | 26,912 | $52.0K |
| Veritable, L.P. | 18,500 | $36.0K |
| Y-Intercept (Hong Kong) Ltd | 18,613 | $36.0K |
| ExodusPoint Capital Management, LP | 16,852 | $33.0K |
| State of Wisconsin Investment Board | 13,876 | $27.0K |
| Kalos Management, Inc. | 14,050 | $27.0K |
| SG Americas Securities, LLC | 13,419 | $26.0K |
| Bayesian Capital Management, LP | 10,700 | $21.0K |
| Captrust Financial Advisors | 1,994 | $4.00K |
| EverSource Wealth Advisors, LLC | 868 | $2.00K |
| Activest Wealth Management | 939 | $2.00K |
| New York State Common Retirement Fund | 489 | $1.00K |
| Credit Suisse AG | 26 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HighPoint Advisor Group LLC | 10,242 | $22.0K |